Catherine Gray
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Prostate Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
-
- COVID-19 Clinical Research Studies 9
-
- Prostate Cancer Diagnosis and Treatment 4
- Renal and Vascular Pathologies 3
- Co-authors
- Jingfei Cheng (10 shared papers)Joseph Peter Grande (10 shared papers)Gina M. Warner (10 shared papers)Karl A. Nath (7 shared papers)Susan H. Backhouse (1 shared paper)Panteleimon Ekkekakis A (1 shared paper)Erik Lind (1 shared paper)Montserrat M. Díaz Encarnación (4 shared papers)
- Journals
- The Lancet (7 papers)American Journal of Physiology-Renal Physiology (6 papers)British journal of surgery (3 papers)Experimental Biology and Medicine (2 papers)The Lancet Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Catherine Gray
47 papers receiving 4.3k citations
Catherine Gray's Hit Papers
Peers
Comparison fields: 5 of 134
- Infectious Diseases 1.3k
- Pulmonary and Respiratory Medicine 1.1k
- Hepatology 288
- Applied Microbiology and Biotechnology 35
- Oncology 316
Countries citing papers authored by Catherine Gray
This map shows the geographic impact of Catherine Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Gray more than expected).
Fields of papers citing papers by Catherine Gray
This network shows the impact of papers produced by Catherine Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Gray. The network helps show where Catherine Gray may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer Hit paper breakdown → | 2016 | 972 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 4 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 5 | Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes Hit paper breakdown → | 2022 | 278 |
| 6 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 7 | 2015 | 227 | |
| 8 | 2021 | 213 | |
| 9 | 2018 | 125 | |
| 10 | 2019 | 115 | |
| 11 | 2017 | 112 | |
| 12 | 1993 | 110 | |
| 13 | 2007 | 91 | |
| 14 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 15 | 2021 | 68 | |
| 16 | 2005 | 62 | |
| 17 | 2020 | 58 | |
| 18 | 2009 | 57 | |
| 19 | 2013 | 48 | |
| 20 | 2012 | 46 |
About Catherine Gray
Catherine Gray is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Hepatology and Nutrition and Dietetics, having authored 48 papers that have together received 4.5k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), Prostate Cancer Diagnosis and Treatment (4 papers), TGF-β signaling in diseases (3 papers), Renal and Vascular Pathologies (3 papers), Congenital Heart Disease Studies (3 papers), Liver Diseases and Immunity (3 papers), Fatty Acid Research and Health (3 papers) and Chronic Kidney Disease and Diabetes (2 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Pulmonary and Respiratory Medicine (1.1k citations), Hepatology (288 citations), Applied Microbiology and Biotechnology (35 citations) and Oncology (316 citations). Catherine Gray has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jingfei Cheng, Joseph Peter Grande, Gina M. Warner, Karl A. Nath, Susan H. Backhouse, Panteleimon Ekkekakis A, Erik Lind, Montserrat M. Díaz Encarnación, Robert James Mayer and Stephen C. Textor. Their work appears in journals such as The Lancet, American Journal of Physiology-Renal Physiology, British journal of surgery, Experimental Biology and Medicine and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.